Marie Billaud

Marie Billaud

Auto-generated profile, based on publicly available information

Marie Billaud

Harvard Medical School

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2012 in Nature
Verified
Journal Article
Open access
PDF file
Adam C. StraubAdam C. Straub
Adam C. Straub
ALAlexander W. Lohman
Alexander W. Lohman
MBMarie Billaud
Marie Billaud
Scott Robert JohnstoneScott Robert Johnstone
Scott Robert Johnstone
SDScott T. Dwyer
Scott T. Dwyer
BIBrant E. Isakson
Brant E. Isakson
This study presents a new model for the regulation of nitric oxide signalling in endothelial cells; the oxidation state of endothelial haemoglobin α, controlled by cytochrome B5 reductase 3, regulates nitric oxide bioactivity and diffusion towards its vascular smooth muscle targets. This manuscript provides evidence for a new model of the regulation of nitric oxide signalling in myoendothelial gap junctions. The oxidation state of endothelial haemoglobin α, controlled by cytochrome b5 reductase 3, regulates nitric oxide bioavailability and diffusion towards its vascular smooth muscle targets by promoting either the formation of vasodilator S-nitrosothiols or the scavenging of nitric oxide. This endothelial regulation of nitric oxide modulates the effects of agents involved in the control of vascular tone, such as α-adrenergic agonists or substances that evoke endothelium-dependent relaxations. Models of unregulated nitric oxide (NO) diffusion do not consistently account for the biochemistry of NO synthase (NOS)-dependent signalling in many cell systems1,2,3. For example, endothelial NOS controls blood pressure, blood flow and oxygen delivery through its effect on vascular smooth muscle tone4, but the regulation of these processes is not adequately explained by simple NO diffusion from endothelium to smooth muscle3,5. Here we report a new model for the regulation of NO signalling by demonstrating that haemoglobin (Hb) α (encoded by the HBA1 and HBA2 genes in humans) is expressed in human and mouse arterial endothelial cells and enriched at the myoendothelial junction, where it regulates the effects of NO on vascular reactivity. Notably, this function is unique to Hb α and is abrogated by its genetic depletion. Mechanistically, endothelial Hb α haem iron in the Fe3+ state permits NO signalling, and this signalling is shut off when Hb α is reduced to the Fe2+ state by endothelial cytochrome b5 reductase 3 (CYB5R3, also known as diaphorase 1)6. Genetic and pharmacological inhibition of CYB5R3 increases NO bioactivity in small arteries. These data reveal a new mechanism by which the regulation of the intracellular Hb α oxidation state controls NOS signalling in non-erythroid cells. This model may be relevant to haem-containing globins in a broad range of NOS-containing somatic cells7,8,9,10,11,12,13.

7 June 2012 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
ALAlexander W. Lohman
Alexander W. Lohman
MBMarie Billaud
Marie Billaud
BIBrant E. Isakson
Brant E. Isakson
The nucleotide adenosine 5′-triphosphate (ATP) has classically been considered the cell's primary energy currency. Importantly, a novel role for ATP as an extracellular autocrine and/or paracrine signalling molecule has evolved over the past century and extensive work has been conducted to characterize the ATP-sensitive purinergic receptors expressed on almost all cell types in the body. Extracellular ATP elicits potent effects on vascular cells to regulate blood vessel tone but can also be involved in vascular pathologies such as atherosclerosis. While the effects of purinergic signalling in the vasculature have been well documented, the mechanism(s) mediating the regulated release of ATP from cells in the blood vessel wall and circulation are now a key target of investigation. The aim of this review is to examine the current proposed mechanisms of ATP release from vascular cells, with a special emphasis on the transporters and channels involved in ATP release from vascular smooth muscle cells, endothelial cells, circulating red blood cells, and perivascular sympathetic nerves, including vesicular exocytosis, plasma membrane F1/F0-ATP synthase, ATP-binding cassette (ABC) transporters, connexin hemichannels, and pannexin channels.

24 June 2011 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MBMarie Billaud
Marie Billaud
ALAlexander W. Lohman
Alexander W. Lohman
Adam C. StraubAdam C. Straub
Adam C. Straub
RLRobin Looft-Wilson
Robin Looft-Wilson
Scott Robert JohnstoneScott Robert Johnstone
Scott Robert Johnstone
BIBrant E. Isakson
Brant E. Isakson
Rationale:: The coordination of vascular smooth muscle cell constriction plays an important role in vascular function, such as regulation of blood pressure; however, the mechanism responsible for vascular smooth muscle cell communication is not clear in the resistance vasculature. Pannexins (Panx) are purine-releasing channels permeable to the vasoconstrictor ATP and thus may play a role in the coordination of vascular smooth muscle cell constriction. Objective:: We investigated the role of pannexins in phenylephrine- and KCl-mediated constriction of resistance arteries. Methods and Results:: Western blot, immunohistochemistry, and immunogold labeling coupled to scanning and transmission electron microscopy revealed the presence of Panx1 but not Panx2 or Panx3 in thoracodorsal resistance arteries. Functionally, the contractile response of pressurized thoracodorsal resistance arteries to phenylephrine was decreased significantly by multiple Panx inhibitors (mefloquine, probenecid, and 10 Panx1), ectonucleotidase (apyrase), and purinergic receptor inhibitors (suramin and reactive blue-2). Electroporation of thoracodorsal resistance arteries with either Panx1-green fluorescent protein or Panx1 small interfering RNA showed enhanced and decreased constriction, respectively, in response to phenylephrine. Lastly, the Panx inhibitors did not alter constriction in response to KCl. This result is consistent with coimmunoprecipitation experiments from thoracodorsal resistance arteries, which suggested an association between Panx1 and α1D-adrenergic receptor. Conclusions:: Our data demonstrate for the first time a key role for Panx1 in resistance arteries by contributing to the coordination of vascular smooth muscle cell constriction and possibly to the regulation of blood pressure.

1 February 2011 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
Adam C. StraubAdam C. Straub
Adam C. Straub
MBMarie Billaud
Marie Billaud
Scott Robert JohnstoneScott Robert Johnstone
Scott Robert Johnstone
ABAngela K. Best
Angela K. Best
SYSean Yemen
Sean Yemen
BIBrant E. Isakson
Brant E. Isakson
Objective—: To determine whether S -nitrosylation of connexins (Cxs) modulates gap junction communication between endothelium and smooth muscle. Methods and Results—: Heterocellular communication is essential for endothelium control of smooth muscle constriction; however, the exact mechanism governing this action remains unknown. Cxs and NO have been implicated in regulating heterocellular communication in the vessel wall. The myoendothelial junction serves as a conduit to facilitate gap junction communication between endothelial cells and vascular smooth muscle cells within the resistance vasculature. By using isolated vessels and a vascular cell coculture, we found that Cx43 is constitutively S -nitrosylated on cysteine 271 because of active endothelial NO synthase compartmentalized at the myoendothelial junction. Conversely, we found that stimulation of smooth muscle cells with the constrictor phenylephrine caused Cx43 to become denitrosylated because of compartmentalized S -nitrosoglutathione reductase, which attenuated channel permeability. We measured S -nitrosoglutathione breakdown and NO x concentrations at the myoendothelial junction and found S -nitrosoglutathione reductase activity to precede NO release. Conclusion—: This study provides evidence for compartmentalized S -nitrosylation/denitrosylation in the regulation of smooth muscle cell to endothelial cell communication.

17 February 2015 in Science Signaling
Verified
Journal Article
Closed access
PDF file
MBMarie Billaud
Marie Billaud
YCYu-Hsin Chiu
Yu-Hsin Chiu
ALAlexander W. Lohman
Alexander W. Lohman
TPThibaud Parpaite
Thibaud Parpaite
JBJoshua Butcher
Joshua Butcher
BIBrant E. Isakson
Brant E. Isakson
The ATP-releasing channel Panx1 is specifically involved in blood pressure regulation by adrenergic signaling.

1 April 2014 in Pharmacological Reviews
Verified
Journal Article
Closed access
PDF file
MBMarie Billaud
Marie Billaud
ALAlexander W. Lohman
Alexander W. Lohman
Scott Robert JohnstoneScott Robert Johnstone
Scott Robert Johnstone
LBLauren A. Biwer
Lauren A. Biwer
SMStephanie Mutchler
Stephanie Mutchler
BIBrant E. Isakson
Brant E. Isakson
It has become increasingly clear that the accumulation of proteins in specific regions of the plasma membrane can facilitate cellular communication. These regions, termed signaling microdomains, are found throughout the blood vessel wall where cellular communication, both within and between cell types, must be tightly regulated to maintain proper vascular function. We will define a cellular signaling microdomain and apply this definition to the plethora of means by which cellular communication has been hypothesized to occur in the blood vessel wall. To that end, we make a case for three broad areas of cellular communication where signaling microdomains could play an important role: 1) paracrine release of free radicals and gaseous molecules such as nitric oxide and reactive oxygen species; 2) role of ion channels including gap junctions and potassium channels, especially those associated with the endothelium-derived hyperpolarization mediated signaling, and lastly, 3) mechanism of exocytosis that has considerable oversight by signaling microdomains, especially those associated with the release of von Willebrand factor. When summed, we believe that it is clear that the organization and regulation of signaling microdomains is an essential component to vessel wall function.